Ignite Creation Date:
2025-12-24 @ 10:47 PM
Ignite Modification Date:
2026-01-13 @ 3:36 AM
Study NCT ID:
NCT02065869
Status:
TERMINATED
Last Update Posted:
2023-09-29
First Post:
2014-02-13
Is Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Safety Study of Gene Modified Donor T-cells Following TCRαβ+ Depleted Stem Cell Transplant
Sponsor:
Bellicum Pharmaceuticals
Organization:
Conditions & Keywords Data
Conditions:
Conditions
| Condition Brief | Condition Text | View |
|---|---|---|
| None | Acute Lymphoblastic Leukemia | View |
| None | Leukemia, Acute Myeloid (AML), Child | View |
| None | Lymphoma, Non-Hodgkin | View |
| None | Myelodysplastic Syndrome | View |
| None | Primary Immunodeficiency | View |
| None | Anemia, Aplastic | View |
| None | Osteopetrosis | View |
| None | Hemoglobinopathies | View |
| None | Cytopenia | View |
| None | Fanconi Anemia | View |
| None | Diamond Blackfan Anemia | View |
| None | Thalassemia | View |
| None | Anemia, Sickle Cell | View |